// App-Quantinova.ai

TCT-639 : Two Year Outcomes Following Implantation of the Resolute Zotarolimus-eluting Stent in Vessels 2.5 mm Diameter

Researchers

Presenter

  • Ronald Caputo

Principal Investigators

  • Martin Leon

  • Patrick Serruys

  • Franz-Josef Neumann

  • Alan Yeung

  • Stephan Windecker

  • Jorge Belardi

  • Sigmund Silber

  • Ian Meredith

  • Petr Widimsky

  • Shigeru Saito

Medical Centers

  • Charles Univ and VFN, Prague, Czech Republic

  • University of Munich, Munich, Germany

  • Thorax Center, Erasmus University, Rotterdam, Netherlands

  • Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina

  • Harvard Medical School, Boston, Massachusetts

  • Universitaets-Herzzentrum Freiburg Bad Krozingen, Bad Krozingen, Germany

  • Deakin University, Melbourne, Australia

  • IBCSG and University Hospital, Berne, Switzerland

  • Shonan Kamakura General Hospital, Kanagawa, Japan

  • St Josephs Hospital Cardiology, Liverpool, NY

Locations

  • Czech Republic

  • Argentina

  • Japan

  • Netherlands

  • Germany

  • Switzerland

  • Australia

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Coronary Artery Disease

  • Myocardial infarction

  • Multi-vessel disease

  • Dyslipidemia

  • Hypertension

  • Venous thrombosis

  • Restenosis

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • ZoMaxx

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved